(Deepshikha Gautam, Intern Journalist) New Delhi: The havoc of the Coronavirus epidemic in the country is now gradually decreasing. Meanwhile, many types of news are coming in the country about the Corona vaccine. The corona vaccine is expected to be introduced in the country by next year. Meanwhile, Health Minister Harsh Vardhan has said that the Serum Institute of India and Bharat Biotech will begin the last trial of the intranasal corona vaccine in the coming months in the country.
The Health Minister said that at present there is no trial of a single intranasal (nasal vaccine) corona vaccine in India, but clinical trials of such vaccines are likely to be done after the approval of the Serum Institute of India or Bharat Biotech in the coming months. Health Minister Harsh Vardhan said that the final phase of testing usually involved thousands of participants. Sometimes there are 30,000 to 40,000 people as well. He said that no nasal vaccine is currently being tested in the country. This vaccine is given to people through the nose, not through direct injection.
Earlier the clinical trial of the Russian Corona vaccine was approved in India.
The Controller General of Indian Medicine ([DCGI)] has approved the second and third phase clinical trials of Sputnik – 5, Russia’s vaccine against the coronavirus. Hyderabad – based pharmaceutical company Dr. Reddy’s Laboratories ([DRL)] gave this information on Saturday. An agreement has been reached between the DRL and the Government Fund of Russia for the trial and distribution of this vaccine in India. Scientists have predicted that corona infection may increase during the winter season. He says that a major reason for the coronavirus to spread during the summer season is exposure to infected small-sized aerosol particles (solid or vapor particles present in the air). Whereas, the main reason for spreading the infection in winter can be through direct contact with droplets coming out of the mouth and nose during exhalation, coughing, or sneezing.
About Post Author
